An immune response module, the STAT1 module, has been shown to be associated with survival in patients with TN and HER2+[21,22], and in the same BC subtypes, the overexpression of immune-related genes was able to identify subgroups of patients with a better prognosis [7,23]. Here, ERBB2 is linked to breast cancer.